HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schwartz, A. R. Articles by Smith, P. L. Search for Related Content PubMed PubMed Citation Articles by Schwartz, A. R. Articles by Smith, P. L.

Obesity and Obstructive Sleep Apnea

Pathogenic Mechanisms and Therapeutic Approaches

¹ Johns Hopkins School of Medicine Sleep Disorders Center, Baltimore, Maryland

Correspondence and requests for reprints should be addressed to Alan R. Schwartz, M.D., Johns Hopkins Sleep Disorders Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224. E-mail: aschwar2{at}jhmi.edu

ABSTRACT

Obstructive sleep apnea is a common disorder whose prevalence is linked to an epidemic of obesity in Western society. Sleep apnea is due to recurrent episodes of upper airway obstruction during sleep that are caused by elevations in upper airway collapsibility during sleep. Collapsibility can be increased by underlying anatomic alterations and/or disturbances in upper airway neuromuscular control, both of which play key roles in the pathogenesis of obstructive sleep apnea. Obesity and particularly central adiposity are potent risk factors for sleep apnea. They can increase pharyngeal collapsibility through mechanical effects on pharyngeal soft tissues and lung volume, and through central nervous system–acting signaling proteins (adipokines) that may affect airway neuromuscular control. Specific molecular signaling pathways encode differences in the distribution and metabolic activity of adipose tissue. These differences can produce alterations in the mechanical and neural control of upper airway collapsibility, which determine sleep apnea susceptibility. Although weight loss reduces upper airway collapsibility during sleep, it is not known whether its effects are mediated primarily by improvement in upper airway mechanical properties or neuromuscular control. A variety of behavioral, pharmacologic, and surgical approaches to weight loss may be of benefit to patients with sleep apnea, through distinct effects on the mass and activity of regional adipose stores. Examining responses to specific weight loss strategies will provide critical insight into mechanisms linking obesity and sleep apnea, and will help to elucidate the humoral and molecular predictors of weight loss responses.

Key Words: sleep apnea • obesity • upper airway • pharynx • weight loss

This article has been cited by other articles:

				P. E. Peppard, N. R. Ward, and M. J. Morrell The Impact of Obesity on Oxygen Desaturation during Sleep-disordered Breathing Am. J. Respir. Crit. Care Med., October 15, 2009; 180(8): 788 - 793. [Abstract] [Full Text] [PDF]

				A. Khan, K. Ramar, S. Maddirala, O. Friedman, J. F. Pallanch, and E. J. Olson Uvulopalatopharyngoplasty in the Management of Obstructive Sleep Apnea: The Mayo Clinic Experience Mayo Clin. Proc., September 1, 2009; 84(9): 795 - 800. [Abstract] [Full Text] [PDF]

				Y. W. Endeshaw, M. L. Unruh, M. Kutner, A. B. Newman, and D. L. Bliwise Sleep-disordered Breathing and Frailty in the Cardiovascular Health Study Cohort Am. J. Epidemiol., July 15, 2009; 170(2): 193 - 202. [Abstract] [Full Text] [PDF]

				H. Tuomilehto, J. Seppa, M. Partinen, and M. Uusitupa Avoiding the Supine Posture during Sleep for Patients with Mild Obstructive Sleep Apnea Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 101 - 102. [Full Text] [PDF]

				K. C. Guimaraes, L. F. Drager, P. R. Genta, B. F. Marcondes, and G. Lorenzi-Filho Effects of Oropharyngeal Exercises on Patients with Moderate Obstructive Sleep Apnea Syndrome Am. J. Respir. Crit. Care Med., May 15, 2009; 179(10): 962 - 966. [Abstract] [Full Text] [PDF]